
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.055 | -1.43979057592 | 3.82 | 4.1204 | 3.765 | 5621 | 3.93912739 | CS |
4 | -0.285 | -7.03703703704 | 4.05 | 4.32 | 3.765 | 4678 | 4.02319619 | CS |
12 | -0.415 | -9.92822966507 | 4.18 | 4.34 | 3.765 | 7247 | 4.1271882 | CS |
26 | -0.075 | -1.953125 | 3.84 | 5.0899 | 3.5601 | 16160 | 4.07632435 | CS |
52 | -0.415 | -9.92822966507 | 4.18 | 5.2 | 2.78 | 12637 | 4.00807491 | CS |
156 | -5.335 | -58.6263736264 | 9.1 | 12.5 | 2.40101 | 41356 | 6.58879451 | CS |
260 | -5.018 | -57.1330980303 | 8.783 | 56.8 | 2.40101 | 670154 | 27.4724175 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約